Thursday, 24 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14482
Articles
Company
Drug
Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group Get NMPA Approval for Solid Tumor Treatment
December 3, 2024
Company
Policy / Regulatory
Taiwan’s TFDA Orders Recall of Two Nucala Batches Due to Glass Fragments
November 30, 2024
Company
Drug
Eli Lilly’s Mirikizumab and Chia Tai Tianqing’s Lanifibranor Enter Breakthrough Therapy Review
December 9, 2024
Company
Deals
Amoy Diagnostics and AstraZeneca Expand Partnership for Companion Diagnostic Development
November 30, 2024
Company
Drug
Vcanbio’s VUM02 Stem Cell Therapy Accepted for Review by China’s CDE for aGvHD Treatment
November 30, 2024
Medical Device
Policy / Regulatory
NMPA Updates List of Medical Devices Exempt from Clinical Evaluation in China
November 30, 2024
Policy / Regulatory
Chinese Health Authorities Unveil Key Reform Tasks for Medical System in H2 2023
November 30, 2024
Policy / Regulatory
NHSA Releases Official Guidelines for Drug Negotiations and Bidding for NRDL Update
November 30, 2024
Company
Deals
Carbon Medical Technology Secures Over RMB 100 Million in Series A Financing for Interventional Therapy
November 30, 2024
Company
Drug
BeiGene’s Tislelizumab Receives Positive CHMP Opinion for Esophageal Cancer Treatment
January 6, 2025
Company
Drug
CanSino Biologics Granted Approval by Health Canada for Zoster Vaccine Candidate CS-2032
December 23, 2024
Company
Deals
Bavarian Nordic’s RSV Vaccine Candidate Fails Phase III Trial, Discontinues Program
November 30, 2024
1
2
…
928
929
930
931
932
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?